Content-Type: text/html

#

    Reference sequence (query): batch____
    Identities normalised by aligned length.
    Colored by: property

    HSP processing: ranked
    Search cycle: 3

                                                                                                         1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :  ] 153
        batch____                                              bits   E-value  N 100.0%   1:153            MIKSWWAEKSTSEKQIVAALAVLSLGVFCWLGVIKPIDTYIAEHQSHAQKIKKDIKWMQDQASTHGLLGHPALTQPIKNILLEEAKRENLAITLENGPDNTLTIHPVTAPLENVSRWLTTAQVTYGIVIEDLQFTLAGNEEITLRHLSFREQQ
      1 UniRef50_Q47VE3        General secretion pathway p...   126     2e-28  1  17.9%   2:146  1:149     -MKEWWQQLNSREQRLVAVMALVFIIFIFYSAIWQPINNSLTEANNKLAKQQELLTWVEENTALyrSGGKSKLSGSISSVANRSAKTYKLTITRMQPQGDDLQVWIDSTPFTQLLFWLEHLANNEGLQVKAIDLTRGDSAGEVKVR-------
      2 UniRef50_Q7MPY7        Type II secretory pathway, ...   120     2e-26  1  19.9%   1:146  7:156     MFQAWWSSISQREQRLVVVCGVFGLIGLIYWGVLQPINARAEQAQLRIQSEKQLLSWVSEKADELTGLRASgsNQPLNQVIASSARQFKVELQRVQPRNEMLQVWVAPMPFNRLVDWLTFLKEKQGIEVEFMDIDRGKESGLVEVN-------
      3 UniRef50_Q089T8        General secretion pathway M...   118     6e-26  1  13.8%   2:153  4:158     -MRSWWQGLAIREQQLVGFCAAVLAIGIMYWGIWTPISNAQDTAERDNSAAQQTLNYVKQTANKIAGLKQAGAqgSLSSVVNQTAGQYKLEITRMQPQGDKIQLWMDDVPFDALLGYLHDLVEQKGLTLDSVDLTESDVAGFVKVR-RIQLSQ
      4 UniRef50_D0M419        General secretion pathway p...   113     2e-24  1  18.1%   3:146  9:156     --QAWWSSISQREQRLVMGCGAIAVIGIIYWGLLQPMSQRAELAQSRIQSEKQLLAWVQDKADGITALRKSssSQPLNQLVSSSARRYKVELIRVQPRNESVQVWIKPLAFNQLVDWLRYLKEQQGIEVEFLDIDRTDQAGMIDVN-------
      5 UniRef50_Q21EQ3        General secretion pathway M...   113     2e-24  1  11.9%   2:152  7:161     -FKEWWGNASSRDQISLVVCSVCVALYILFMGVLSPLYDMRDAQVRSHESAVVTLARVKELAAQIKGSggRSGGPSIVDLVDSSLRSHGLRLSNMQPSgsDVRLRLDEVSFNSLLAWLNEMEVEKGLQVKDMSIAESSNIGMVSVTLRLHQE-
      6 UniRef50_C8UAZ7        Type II secretion protein E...   112     4e-24  1  12.8%   2:149  4:156     -LKKRLQYISPRERRLLTGCVALLVVAFVYYVFWLPWQVREDKWRTVIAREKYTVEWMKQQIPSIKKWEASMPEqgLSAAVTQTSAAYGVSVTRLQPQGERLTVTLAPVEFNTLMQWLTQLHRRYRIRTVVFDVVAQGnpGHVTVNRLV----
      7 UniRef50_P41851        General secretion pathway p...   111     7e-24  1  14.5%   2:146  8:157     -VQAWWRSVTPREQKMVMGMGALTVLAIAYWGIWQPLSERTAQAQARLQTEKQLLSWVSENANDIVTLRaaPSDQPLNQVITNSTRQFNIELIRVQPRGEMMQVWIQPLPFSQLVSWIAYLQERQGVSVDAIDIDRGKVNGVVEVK-------
      8 UniRef50_B8GU53        General secretion pathway M...   106     3e-22  1  13.4%   2:150  1:157     -MKAWWEGLNQRDRRILMVGGALLCLLLPYMLIWQPLHDRAERLERTLVAQRADVSWmqLRATAATGRTPTPAGQSLLGMIDRTVrqLGGTVRRVQPEgnTVRVWLEDAPFDELMTWLGTLETRHGIRATSLVVDRQATPGRVNARLTLE---
      9 UniRef50_Q2SFC5        Type II secretory pathway, ...   105     4e-22  1  13.0%   4:149 18:172     ---TWFYGLSQRDQTALKWMALVVAAFSVYMFVWAPVQDFVESSKNSAEASHESLTWMKENEARARASSRqsGGQSLLSTVGSSARKFGLELQRFEPRgdKVNVWLDKVSFNQLMLWLGELEKNYGVAVEQITVDKADAPGVVSSRLSL----
     10 UniRef50_A6FGY6        General secretion pathway p...   105     6e-22  1  17.2%   2:146  1:149     -MKAYWQQLEQKEKQLISILIVTLVLACGYWLLWQPLQHDIINTQRKVNVQTQTLADvqKIMDLQGGKGKRSEAGDLNQLVSRSAARNQIVITRIQAKSDTLQIWIDDVNFNQFTAWLERLNKQYGIEIQNIDLSVSDAKGMVKVR-------
     11 UniRef50_P41850        General secretion pathway p...   104     1e-21  1  16.6%   2:146  5:155     -LQGWWRSISAREQRLVAVGGSCLLIGFCYWIVWQPIANRIAERERQVLSQQQTLAWLKEkaMQGGQGRQIDTSGTLEGVVNRTAFNQKIKIARLQPQGQELQVWIDTVQFDDLLIWLASLADQHGVQVQVIEVAREnaPGLVKVR-------
     12 UniRef50_A0YBF1        Type II secretory pathway, ...   103     1e-21  1  15.4%   2:150 14:167     -FSVRYESLENRDRLAIKLLLGFIVTVIIIFGMILPASNYKASSEAYYRNSLETLTWMQGNKPLiqRRLVRDSGQSLLGIANKTSKGFNLTFKRYQPVGegLSLWLENESFNNVILWLERLDKRHGISVDEISVDRDEQDGLVSIRLVLQ---
     13 UniRef50_C5BM29        General secretion pathway p...   103     1e-21  1  14.6%   2:152  4:159     -LKEWWNKASTRDQLSLAIGGGILLLYLCYMVLLKPVTEMRDNQLHRNMAQAEALERVRELAATWVNREgsDNGRSLVDVVNSSLQQNSLRMTGMQPSgnDVRLRLEQVPFDNLLAWLYDIEVSQRLQVKDISVATGSNEGLVSVNIRLHRE-
     14 UniRef50_D0I3A1        General secretion pathway p...   103     2e-21  1  14.5%   2:146  4:154     -LIAYWQGLSRREQRLLGVASAVILLGTLYWGVVSPLQAKAEQAEQRLASERNLLSWVNSKAAEIEALRRAtsALPLNQSVTTTVKRYNLEIVRLQPQQEEIQVWLKPMPFNALISWLDDLSVNHGVQVKFIDVGKTETLGVVDVK-------
     15 UniRef50_C4K3F9        Putative uncharacterized pr...   102     3e-21  1  15.2%   2:146  1:151     -MKQRWHHLSLRERYFLIGGVFCLLTFLSYSLVWQPLQKKILLAQKKLEQHRQLLHQIHLAKPALKEWLNRrpDESLSNIVHQSAAQAGMEIIKMQEEEKALRVWIAEVSFKKLVSWLFDLQYRHGIQTAYLDLVETGIPGIVEVQ-------
     16 UniRef50_Q1ZIZ1        Type II secretory pathway, ...   102     3e-21  1  19.7%   3:149  6:157     --RIWWATSNIKERRLVVVIVLFLAFSLCYWGAWKPLSTRLDNSEIQLLRTQKTLSWVQEKASLlgSQVAQVPQSSLVEVINRSAKRSGISFTRILNRNDTLEVWIADVEFNNTMDWLTLLKNKYGIEVLNVDINQALKPGYIKINRLV----
     17 UniRef50_C6XJ56        General secretion pathway M...   102     5e-21  1  14.1%   1:149  1:153     MIKNWWAAREPREKLLLSICLVLTLTIVLFQFIFGPSVEFRDRASKRYLSQASSHSEVVQTLRVYENSPraVSAGPVQGVVSDSSAVFGIDISRIEPTSNglTLWIEEIDPQSLYAWLTDLEINHGISVNKASIRMNKDTVTVNANVLV----
     18 UniRef50_A8AIM9        Putative uncharacterized pr...   101     8e-21  1  18.9%   2:149  8:155     -LKARYQNYSDRERGLITLCAAAMCCAVIYYGGIIPLDHMIQNSQSTLMRQKETLRWMRDEIDKNHLQAKVLKTNNPRTVIEESAKEIHLALSDIRQDERSLSFVVEQVNIYELKNWLREVNVTSGVQLQKMDLRPVDRQSDVKANITL----
     19 UniRef50_UPI0000E10E09 general secretion pathway p...   101     9e-21  1  12.4%   2:146  6:154     -LSDWFSQLAPREQALLKVGSVILIIAGFYGLVWAPMNASIERETKLLAQQQALSTWVVQQQAKVLQFRRQGPggSLVQAVNQTARASNITLTRMQPNNDEVQVWIDEVGFNTLMTWLGSLDTT-GVRVLQVDITEAGAPGNVKVR-------
     20 UniRef50_Q46832        Putative general secretion ...   100     2e-20  1  13.1%   2:146 25:171     -LAQHLAGRSPREKGMLLAAVVFLFSVGYYVLIWQPLSERIEQQETILQQLVAMNTRLKNAAPDIIAARKSATTTpvSRVISDSASAHSVVIRRIADRGENIQVWIEPVVFNDLLKWLNALDEKYALRVTQIDVSAAEKPGMVNVQ-------
     21 UniRef50_P31709        General secretion pathway p...   100     3e-20  1  15.2%   2:146  4:154     -LRQRWQAMSQRERQLMVVCAAVLLLCVVYYAILQPWQEREDLWERTISREQQTVNWMQKQASSIPRGNQAQgdVSLPILISQSTKRYGLTVVRLQPQGSQASVTLGQSDFNSLLRWLGELEQKNGVKVISLDVNAVEqpGIVDVT-------
     22 UniRef50_A3SDU2        General secretion pathway p...    99     6e-20  1  14.2%   6:153  4:151     -----FAALNPRERRLVGIVLPLAIVVVGYQFLWAPLHRAQAEARADIQAFRLVQDTAALASVDTIVSLQPLNETPLATRITTSASAANLTLRRIEPENDSIRVTLDDTPFATILLWLSDLEEQHDVRVEALEVDRRPAPGRVSARLLLGSLQ
     23 UniRef50_A4BDW7        General secretion pathway p...    98     8e-20  1  16.2%   2:149  9:158     -LREKWLSLSRRDQQAARLLGISLLIAIIVFGLIVPLASWRQDLQRELANAQQTLQELTALAPQAMAVTGGATELNPssEIRRQAARYGIEIQRFEPDGELLRVWLDDARYPSVVQWLGGLE-NMGIGHTELALDDRPNPGFVNVRVTF----
     24 UniRef50_A5ID27        Putative general secretion ...    97     1e-19  1  14.2%   2:149  1:153     -MKTYLNTLNDREKWMVIVAGVSLFIYGYYLLLYAPLSNQVNQKSTQLIEKTETLEWMK-QVRMQKRSAKRKESVDNSQLLTILASqlKFPYQLQQTGSGDVQLTFDEVPFQNFIQWLAKINEVYSINIKQFDVEKTPTPGVTRLMIIL----
     25 UniRef50_A3MPL1        General secretion pathway p...    97     1e-19  1  12.8%   2:150 17:170     -LSQFWEARTAREKLLLGWGGAVLALAIAYSVLWSPAQEGRARIQRELPTMRHELAEMTAQANEARTLAGAAqgVALKDALAASLSDHGLAAAAPQVVGGGVQIQLKNASFPAWTQWLDDVRRQFKAQVVEAHVSALKEDGQVDLTAVLQ---
     26 UniRef50_Q3ILM0        Putative general secretion ...    97     2e-19  1  14.9%   2:149  5:154     -LIKHWRSLKEQEQQLIIVASGIFIVFILVMGIFRPLNNAIASAEQSQLKQQELLVWVDESIVKLKAAGNTqnSQNISQIVNATRGRYKINISKMQPSNNSLRLTLDSVEFNQLILWLDELVNQHGLRVENLDLSRDDKSGYVRVSRLL----
     27 UniRef50_A0YG42        Type II secretory pathway, ...    97     2e-19  1  13.9%   2:152  1:158     -MQHWFYSLKRQEQIVLLFGIVVVFSYLLYVVVLRPLSAAVERLEQKNEVASRSLNVVEALSKEYQSLKKKSGsqNLTRLIDTTVKNNTLTMTRFQPSSSgvQVRFENAVFDNILSGLHELEVGNGIVIKDLSVTNGSATGLVNVSVRLRQE-
     28 UniRef50_Q15ZB6        General secretion pathway M...    96     3e-19  1  19.3%   2:146  4:152     -LKQKFSQLTEREQRLVLISAVVVVVGMFYWLVWSPLNQAIERDQKALDSQKSLLSWVQKSANRAIQLRAAKgnGSLAQAANQTAANANIPIARMQPQGDELQVWVDQAPFNGVLDWLKSLEE-MGVSILDLDIAEADAPGQVKIR-------
     29 UniRef50_A1WZN8        General secretion pathway M...    96     4e-19  1  13.6%   5:151 16:172     ----FWSARNPRERWLLGSGGLLVLVVVPYVAVWEPLTERRDQLQAQVAEQRQDLAWMRSAAEEigSAEPVTDERSLLSLVDRAAREAGIDDqrVQPDGDglRVWMDRVPFDELMNWLDGLQRAAGVEVDALTVERTQEDGLVNVRLTLEV--
     30 UniRef50_Q1N4H7        Type II secretory pathway, ...    95     8e-19  1  14.0%   2:151 25:176     -VHNWYSQLGTNDQSIVKVLLFVISLVLIYAWIWQPAVDARDAANKSFNKELSFHESLKENAYRFksSSNQPSGGSILSIVSATAKAKKIELRRFEPDgtRLRIWLDKAEFDAVIDWIEILEAEKGILVEQISLDKVS-SGRVNVRAVLTQ--
     31 UniRef50_P36678        Putative general secretion ...    95     8e-19  1 100.0%   1:153  1:153     MIKSWWAEKSTSEKQIVAALAVLSLGVFCWLGVIKPIDTYIAEHQSHAQKIKKDIKWMQDQASTHGLLGHPALTQPIKNILLEEAKRENLAITLENGPDNTLTIHPVTAPLENVSRWLTTAQVTYGIVIEDLQFTLAGNEEITLRHLSFREQQ
     32 UniRef50_D2TMG9        Putative T2SS protein M n=1...    95     8e-19  1  25.5%   2:150  5:155     -IREWLQQKNPTEQRIVIALFILCVATIYGCGLWLPLNHTVDALQTRCNKLRQDMAWLEKQAQARGVLPQRTPEEPVASLLKKEAEQAGFSVTLTQNSADGVEISANDISQQAFTAWLTRLQSRHGLYVETLEfsPAKADAITLSKMTVR---
     33 UniRef50_D1RFN4        Type II secretory pathway p...    94     1e-18  1  12.3%   2:147  1:151     -MKSYLSTLNEREKWMLIGTGLCLILYIYYLFLYTPLNNRVNQKSTQLVDKINTLQWMK-KIKQQGRTTQTKQVVSNSQLLTALATqlKFPYQLQQTGSGDIQLTFDAVAFNLFIAWLEKINQGYAITVKQFEADRTKTPGITRLMI------
     34 UniRef50_O32575        W0031 n=14 Tax=Escherichia ...    94     2e-18  1  12.8%   2:149  4:156     -LKKRLQYVSPRERRLLIGCVALLVVVFVYYVLWQPWLIREDKWRTVVTREKNTVEWMKQQVPNIKRREASMPEQglSAAVTRTSAAYGVSVTRLQPQGERLAVTLAPVEFNALMQWLTQLERRHRIRTMVFDVAAQGnpGQVTVNRLV----
     35 UniRef50_B3PEM1        General secretion pathway p...    93     3e-18  1  12.0%   4:153  6:160     ---AFLNRYQRREQIALLALGIAVVIFLLWILILAPLQKKREQLQTANTAATQTLGKVRIMAAQIQQArqARSGENISGLIDSSLRGNGLTMSGFQPgaGEVRVRLDRAAYEPLMQWLYELEFKHGVSVRDLSLAATNDPGLVTVNLRLQKAQ
     36 UniRef50_D0XKE5        General secretion pathway M...    93     3e-18  1  13.6%   4:150 19:162     ---AWYAGRSRREQVLLAVLGGFLTVAVLWLGILQPLLDARATAIGRIAAYETVMVRVRTAGP--VGATAAGLSGPLETAIPAQAATFGIIPASVTPDGDAATVTVTEARYDSVVPWLAGLEAS-GATLSSVRIDRGSQPGVVNVSVRVQ---
     37 UniRef50_Q0A613        General secretion pathway M...    92     5e-18  1  13.2%   2:152  5:163     -LLAHWQGLEPRERRILLAGALVLAVLLPWGGIWLPLSDRAETLRGEVAEARAQQAWMAAAAERVRQAGGATaaDSLLGRVDRSAGDYGlrLERLQPDGdrVRVWLERADFDQMLYWLDALAET-GVRVHALSLEPLDAPGRVNARLTLESE-
     38 UniRef50_P15752        General secretion pathway p...    91     1e-17  1  14.6%   6:149  8:154     -----WQQRTRRERCLLLGMAVVLLIGLVYYTLWQPWQNREAQWRQTLAREQASLQWMRQQTPLIRQLRNQKppEEPSTVIMREAARHGLTIVRLQPQGSRLSLTVQPADFQALMAWLDALGQAGMTTATLAVTAVAQQPGWVTVNTLV----
     39 UniRef50_A4A5K6        General secretion pathway p...    89     3e-17  1  16.9%   2:149  1:155     -MKDWFERYTLREQLALLAMALVVTLYLLGVFVIQPLGQARADLAARNTATAEALLRVDAMATEIRALerGTRSANLSASLNQSAGRYALRVSRLQPNSQgvQLRFESAPLDALLRWIHELETTQGLRVDDLSLSQTSTAGTVSATLRV----
     40 UniRef50_Q3BXL7        Type II secretion system pr...    89     4e-17  1  11.4%   5:144 11:150     ----WWQTRAPRERRMLGVMCAALAAFVGWYALYMPLRHWHDRAWARYADAAQLVLDASAQAASTRHTAAPGPA-ALAKIIASSARDAGVNITSQQRsaGGVEVQIEAVSAATLFGWLKRLRQAHGLAPTQLHVAREQGQLRVR---------
     41 UniRef50_B5JVC5        General secretion pathway p...    89     6e-17  1  12.0%   4:153  2:158     ---EWWHRYSQREQRTLLAGGAVLAVFLIYMLLLEPLVDFHQQGKADLETHRELHQWMAQAVAEYRSIGGsaSSGSVAVAVENALKQSGLpaTRIAPKGqaVSVSYDSVAFDRLMHTLDKLTLDQGLQLAQFQASAVGDERKGMASVEFELER
     42 UniRef50_Q0VPY0        General secretion pathway p...    88     9e-17  1  15.6%   4:150 20:171     ---QWYESREPREQHILKILAVVAFVVLLYWLLWAPSVAARDQAKKQFMVNQQTLQWIQDNREAVIAARRSdpNGNWTGNVSRSADQFGLTLKGFSPDGNrvRIQMENQATSQTVLWLQSLQQS-GIQISNLEMTPGEKSGTATVRATLQ---
     43 UniRef50_Q1NDR5        Putative uncharacterized pr...    88     1e-16  1  13.6%   5:151  7:157     ----YWAERSPRERWMLGVMFALLAIVILWFGIAVPLDRAQRDARDRLVEATERNAAIRATVAQLKALPRAPAnvPLDQFVGQSAGEAGLTLERAQAQgdRMDIAIASVRPIALFSWLSTLE-GQGVRVVTMSARPSPTAGSISVQAVLER--
     44 UniRef50_B7RST8        General secretion pathway p...    87     1e-16  1  11.5%   2:149  1:153     -MKQWFTGLTQREQLSLLIMGLAVALYLAFVIVIAPLSQARDRMVVQNRGVAESLQRVEVLVSQILHLrgSSTNRNLASLVNRSTSSYQLQVNRLQPNsgELQVRLENAVFDDLIAWLYQVEYKEGLRVLETSITQAGTVGRVNATVRL----
     45 UniRef50_A1SR65        General secretion pathway M...    87     1e-16  1  12.4%   2:146  5:154     -LNTWWESITEREQQLSLVSVLLILIAIIYWGIWQPLSIGLDNSENQLQRAQQTLSTTQQRATLLVSAgaVSENQNVTQIVTISAQQNGITFSRIINRNEQVEVQVSNVEFDRFINWVSVLSSQYSVSVLNADISRADEEGYIKVT-------
     46 UniRef50_B7RHZ7        Putative uncharacterized pr...    87     1e-16  1  13.5%   6:153  4:152     -----FNRLSLRERILVLIALPLVILFAGYRFGWVPLSEARTAARVEIQGYQTLIEAAENQGNqvEVATVAVVTTPLATRITDSAARAQVLVRRLEPEGALVRVTLDDAPYDAVIKWIAAMETDAEIALVAIEMDRRTAPGIVAARLTLENAQ
     47 UniRef50_A3WP21        Type II secretory pathway, ...    87     1e-16  1  11.9%   3:153 21:175     --QQRWAQLAVREQNLVKGLGAVIIVAIIYFAIWQPTYSAQQLAERRLEGQQQQLLWLREQVARYQSlaQSEVSGSLSQRVNEAAASNKIQIARMQPQNNGLIVSVDETSYQQAMSWLYALEQTYQLQVTTLDLARLDELGKVRVRQVLVTEK
     48 UniRef50_C4L989        General secretion pathway M...    87     2e-16  1  19.6%   2:149  1:153     -MKQWWQDRTTRERRIVLAAALVLLSIILYWNVWSPLQQHLQQQRGQVQQLQQQLSWMQQQAPLVRQLKQQSASpdIASTLSNSSQGYQIVLKRIQPQGTNALVEMDTTSFEQLVSWLNMLEQQYGITPQQIDLQPAEVPGKAQVRRLL----
     49 UniRef50_Q31J18        Type II secretion pathway p...    85     9e-16  1  12.2%   6:153 14:167     -----WKGFSQRDQRAIMILGGVLLCAVLYFLIWLPSEHAKQQAQQKLALSQQKWDWLNEQLPKVAQRGPVLPASTLkqFIQAQLRQLNltIERIETQGHKVVVEFKEVNAPRLFRWLSQ-QEQQGLIAYSADLKPLQ-PGIVTAKVIFEVSK
     50 UniRef50_C7R8F1        General secretion pathway M...    83     3e-15  1  14.2%   2:149  4:156     -IKTLYSGLQKREQNMVLALGIAMTILLVFLLVVLPLKSYFDNLNDDLSYYESQMVTVQKQVAAIKSAGPAKanVSLNQLVNQSAKSFGLSFSRIeeRNKEIQLRLDDVEFDQLLRWISLLEQERGLVVDTLRVSKKDTVGKVDASIKL----
     51 UniRef50_B7UZ45        Probable type II secretion ...    83     3e-15  1  14.4%   2:140 25:165     -LQAYWRQLAPRERKILAGGGLALCLALTWQVFIDPPLARIEHWQAELPRLRAQAAAVDGVLREVEALRGPTLSGTADAeiRRSLRDQGLdfQLDAPQPGQWQLDFASVSGEALLRWLARSPAALRLSVSEAQVTRLDAP-------------
     52 UniRef50_B3R7X0        GENERAL SECRETORY PATHWAY M...    82     4e-15  1  16.8%   2:150 45:198     -FDAFWSARNPREQAILAGGAAVLALVLGYLLLWEPAADGRDRAARNLPQLRADLAEMETLAQEARGLKATPagDELTQALQESLGQYGLKATRlaAADNSVQVQLDKVPFGAVSTWLQDVRQQQRMKVIDARVVYVGATALVNVTATLQ---
     53 UniRef50_A1U0C6        General secretion pathway M...    82     5e-15  1  15.5%   2:149 14:175     -LIARYDQLPTRDRQALTALGIALLLALIYLLIWQPVTQFHDRAASSRENAAELLAWMRANETTIQRLgkPEDGRALMALVTRSAGEAGLSLQRFEPSGEgiRVWLENAAYADVAAWLERLHSNHGVVIDQAALDRGNGPGQVSVRLTL----
     54 UniRef50_Q1IB25        Putative type II secretion ...    82     6e-15  1  15.2%   3:153 15:160     --RQRWQALAPRERRAVALAGAVLGSFFCWQVLVAPALTRIEHWNTETPKLRSQAQALDALLGQ--------RSADLAGALAQSLDEAGLRasQLDAEGDGWHLAWRQAPAEPAMAWLQRIPPRLGLTIGQLSLRRDPGAGtvTFSGTLRMDQ
     55 UniRef50_A0Z781        Putative uncharacterized pr...    82     8e-15  1  12.1%   1:149  1:153     MLGDWFNARPRREQLYLLSMILAVGVWVVVQVIILPASAARQQMEINNQRASEVLTRVDAKATRLVALRSAAQssSLTAAISRISKLEGLVVRRLQPNsgEVQVRFEAINYDALVKWLYRLEVTEGLLVIDVAIVRSSGAGGVNATIRV----
     56 UniRef50_A3UEX1        Putative uncharacterized pr...    80     1e-14  1  19.7%   6:152 14:164     -----FQARTAREQALLAGLAVLVVLTIAWFGVLAPAMSWRADAARRYANAAEGYESILVQASEYRALSAQAVNapLRTLADRTARERGLAISRVQpeDGRLGVWMEQADADSLMGWLSLLSREHGVNAERVSLDREGET-RVRAQLTLVRA-
     57 UniRef50_Q0C118        General secretion pathway p...    80     2e-14  1  11.3%   2:142  1:151     -MTGWWNTRTPREKMLLAIAGFILAVAVIWQLVLNPAIHTLERAKRSHEQSAQTLARLDRIESLMQqaPSTQDTAALLSEAERMAREGNLLLSGSEPAssSFRVKLSAVSGPAFFQWVEQVETGLGVSVSAASLTQNADGSM-----------
     58 UniRef50_A4VFT9        General secretion pathway p...    80     2e-14  1  17.6%   4:151 18:168     ---QRWQRLAPRERTSLSLLGAFLLAVLFYLWLWLPAQRQAAEARDYYQAQRELHAYMEQNTELARQMERSNqpEQLQGVITESAQQGNLSIESFDNGSDglQVSLPGASYALLLRWFDTL-QGQGVSVTEVSLERAGE-GLVNARVSFRA--
     59 UniRef50_B8L5U1        General secretion pathway p...    79     6e-14  1  13.6%   2:148 15:162     -LQQRWQRLPPRDRLMLGVMMGALLVAGLWSFWLEPLLKQRTHWQAELPRLQAQANALAPLLRARERQQQARDQRPTLAGLRERIRSAGLAEGliEARDGRWHLRVQGVPADALWNWLLPVLADPAIELQQLQLTRTGDANMPAARIS-----
     60 UniRef50_Q2Y7T4        General secretion pathway M...    79     6e-14  1  14.6%   2:152  5:160     -LRKAWESRSPRERRVITILGMIL-SAGLYLGLVSSADRARTRLRSNLPQLRVQAEEFEQQAAEYERIKVTPSPPPLSGDLHALAQTQADILGLSHagDDQVQVTFKAVPFADWLKW-TVAMQLQRVRFEKGRIEALPEPGIVTVTGTFVRA-
     61 UniRef50_A5V9H7        General secretion pathway M...    79     7e-14  1  16.4%   6:151 24:168     -----WQARSRREQWLLGGLAAMVALYVLVAMVILPVQRARAQALSDIRTYESLSARLRSAGPLGQAPAQPQAGGSPAAVLSASAARFGMVPV-VNEGGEGIRVTVADAPYESLLRWIAEVEQTSRLRVVRLRLDRRPSSGFVSAELMVRA--
     62 UniRef50_Q0ASQ4        General secretion pathway M...    77     2e-13  1  17.8%   4:149 10:160     ---AWWDGLSSREQVMMAVLGALAMILLVSLLIIQPLLGAHDRARDSYAASMRLYRAVEADADTVqaPASTAPAQSLRAVAGSMALRHDIALARMVpeDGRLTVNIDRAETAAILAWLVDLDRRYGIRAQASTLDR-DADGFVSASFVL----
     63 UniRef50_Q2G4Y9        Putative uncharacterized pr...    77     2e-13  1  14.6%   2:152  5:157     -LNVWYGGLTARERGLVSVAGGLVASIVLVYGIVLPVGTALDDAADRHRNATERAGRIEAQIAALKAAPaaVLAGPVEQIAGASAQEAGFVVQSNQRRGSDMAvlIPTARPSAALAWLDGLMA-QGLAVEQLTMTPAPD-GSVSVNVTLRRS-
     64 UniRef50_Q5QY94        Type II secretory pathway, ...    76     3e-13  1  10.0%   3:152 16:170     --KQRWQQFNQREQSLLAVLAGVLFIAFLYFVIWQPSSQAVANAERQLAAQQQQYQWVQQAIARYKKleQQSASGSVSQRINRAAAAQDIQIARLQPQGQEYLLSVDEVAFSDLLSFLAELEQRQGLSLKAVDIAKLNTPGQVRLRKLLVSE-
     65 UniRef50_B8KQL9        Putative uncharacterized pr...    74     1e-12  1  12.6%   2:152  1:155     -MKTWFRQLPQRDQIALLLLAGALSLWLVYQALLMPAKTQRERLLATNDAAAQLLGRVDTKVSqlREQGGSRRSQNITATINSTTRALGIAVQRMQPNsgEVQIRMEDVDYDLLVRWLHRIEVVEGLLIVEASIAQSGRSGSVNASIRIAQS-
     66 UniRef50_A3VSL0        Putative uncharacterized pr...    74     2e-12  1  15.5%   2:149  1:147     -MTEFWYARSVREQRIILAGAGALLLLIFVLLVVQPLIDYRRTAIADHQRAMDTYLAVTRAVSRASAGPVREPSV-LRSTIDRVARERQIVLTRTAIDEDAVVVSTGGVTTATLMNWLDTLRDEHHIAVRDAQIRPASAGNGVTARLTL----
     67 UniRef50_A3YCB4        General secretion pathway p...    74     2e-12  1  14.4%   4:149 19:170     ---QKYQALSKREQKLVACLAFVLFIYLLYSLLWVPIHQQKEVAQKRVDANLKSYYLLVENAPLLTKSLGDssGQALQALVSRTMRKQKLVAQRMNLDGdrLQVWVENTSYSDINKWMTILAKEK-VSIYSVQF-ASRELGVVDMRLTL----
     68 UniRef50_C3KC63        Putative general secretory ...    73     3e-12  1  20.3%   6:153 38:187     -----WRGLSRREKRMVAGTALLLVGLLSWLVLIQPALKKIEYWQAETPKLRAQTEALERL---LREVPTPTAGQPLEPALRQSLDARGLvyYQLTPVETGWQLTFETAPADAVIGWLVSNPRQFSLEVVEARLQRAgdDTAGTLSGTVRMDQ
     69 UniRef50_Q48JN4        General secretion pathway p...    73     3e-12  1  15.0%   7:153 21:175     ------AGLSIRETRLLSIGALVLCCLVTWLLMVQPALKKITYWQAQNPVLSAQAETLETLLKQVRVPQRRTGPQDLQPALQRSLEAFGlsYCQLEQDGerWQLAFDHAPADAVIGWLLEQPQLFSLHIKDASLQRAGEDAqgHLSGVVRMDQ
     70 UniRef50_D0KWL7        General secretion pathway M...    72     6e-12  1  10.8%   2:149  8:165     -FSSFWQQRNQSERRTLTLAAIALVALVGYQFVWSPMQQAVQRAHDRLAQAEQLaaQAKKALMQAGPKSAQPSADSPMLWVEQAARTVGIEQQLVQRqdDRVQLKFAAVPFDLLLRWLAQ-ANDAGLSVQSANITpsDAAGLVDAEITL----
     71 UniRef50_Q6LM86        Hypothetical MSHA biogenesi...    71     8e-12  1   6.6%   2:137  7:137     -LSDRFDLLTRREQILILVSGWVALLFVGFVVVIEPTMKDVTSIKRQLVSAANELVSSDNQIAAINRKLNSDPNNDVDKKIERLEQQ---TDGLNEQLTDRVASLVTPIQMSGLME--EVLRRTTRLKLISLESQAP----------------
     72 UniRef50_Q8KTJ4        GspM (Fragment) n=1 Tax=Bur...    71     1e-11  1  12.9%  19:150  1:137     ------------------WGGAVLAVLIGYSVLWSPAQEGRARIQKKLPTLPHELANMTAQAHQGKSLPPPAQGValKNALTGSLSDHGFKGAQGQGVGGGVQVQMKNVSFPAWTQWLDDARRQFKGQVGEAHATALKDDGQVDLTAVMQ---
     73 UniRef50_Q1GWC5        Putative uncharacterized pr...    70     3e-11  1  18.8%   2:150  5:156     -LKYWWAGLSGRERWLVGI-AAVLALGVLGWGLGRPAVAAFIDLENRHRAAIEREGRVAAKVALLGARPqsADAGAIDQFLQQSAGEIGLTLDRNEARgnRAAIAIATAKAPVLTDWLASLEA-QGFVIDQLTITPA-ADGTVGMTAELR---
     74 UniRef50_D0I544        MSHA biogenesis protein Msh...    69     3e-11  1   8.3%   2:133  8:134     -VKGAFEALSSREQWMIAIAGWIAILGLGVAVFIEPQGNALAQLDAQIMQSEHTTQDLQALNRLKQEKLQSSPNTELEAELERLNQTLSSLDSEIARKVDGL---VSAAQMSALME--SVLRQSDRLTLMSMR--------------------
     75 UniRef50_Q3AED7        Putative uncharacterized pr...    69     4e-11  1  12.2%   5:152  3:177     ----FWEKLAPRERILVGIALGLTVFYLLYYYAIMPNWQKYQELKTELNTVNAEWERLqeNVLATEVKNKEQLEKELKNilLASAKEKNIRLLEFKPGSveFPVEIKVQgyPQVLEYVESLENFPDleIKNLTISSVPGDVRGNVEAAFTLA-
     76 UniRef50_B8GXS2        Type II secretion pathway p...    69     4e-11  1  16.3%   3:149  9:153     --RLWWTGRTGREQVLLAVMVAALVVVIGWYGVATPLWSAAKTAQVRVDKAATQLATLRGLAA--GASRATAGGAAPQAVVEAAASRVGLPIArrQDANGRFTIWIAAIDSKILLPWTAGLEREGAVKVTDFTASRLDN-GLIEAEITF----
     77 UniRef50_Q8GBD7        Yts1M protein n=2 Tax=Yersi...    69     5e-11  1  21.7%   2:153  4:157     -IKQRWQNYSKREQLIFSLGGLVLLGLIVSQGIVAPLENYQHQSTQNLHSAQRDFAALLQQQERISRLQAQRPPqsADRALHESAHQKNMTITLLEANANRAVVAPLTLPFSQLLSWLEQLEAQYGLQASQLKLV-ADVDNLSRVHITTLVLQ
     78 UniRef50_A8ZWZ2        Putative uncharacterized pr...    69     7e-11  1  12.1%   4:152 11:180     ---TFFRGLTPRERYAVCIGVAAVLLLFFWKGVAAPLSDKRETLVVQLASRQNDLKQmqAAARAAAGQSGRGADFTLFSFLDRLAGRAGIkiAYMRPSVSgvEMKLEGVDLQGLVSYLHMIETADAMvvTRLSIAAQEKGGGGGVEAVLRVE-
     79 UniRef50_Q7MHC2        MSHA biogenesis protein Msh...    68     8e-11  1  14.6%   2:138  1:139     -MKQQWNalSGREKWLITLCGLVVIVLLLFTLVIEPAWKQLAAKKEQLSSTIQLNQKLQGDILVIQAKLNKDPNREIDIEMKslARSQELGMQLSEVIGNLLS----PSQMAELLE--TVLDKSSGVKLISLESLRAE---------------
     80 UniRef50_C6P582        General secretion pathway M...    68     9e-11  1  14.4%   6:151 13:163     -----WDVLGATEQKTVIRGAWILLPLLMYGLLWQPAHQALPKLQTALPQLRAQAAQMQSLAGQVQSLRQQadSDALKIAVEKAASEANLPLQIVPGEPNSVRISADSIAFAQWLQWQRSLEQTHHIRVSSAMLVATTETGMVKVQATLTN--
     81 UniRef50_B8FE39        Putative uncharacterized pr...    68     1e-10  1  12.4%   7:151  2:169     ------NRLGNREKLILAAGIFVAFAILVHAFIITPALEGSRKRQAELRKMESNLVSIMELAEEYKKAKMNTndFSLDNYLGQLARQAGvsSKKPIANSDFVqiKLDDVTTEELLNYLHKIETSPnlSVRRITVTRSQREDDYGVSATFQV--
     82 UniRef50_Q15ZI8        MSHA biogenesis protein Msh...    67     1e-10  1   9.7%   4:137 14:142     ---AQFLAITQREQILILLSGVVVIGMVGYLLFIEPVNETVTRDEQNIASMRNQVRSVEAQIEVSEHAFSNDPNEQLVASLN------KLKQRSLDLDTDLQQETVNLVPPKQMPLLLEklAESQGVTLISMQSIPP----------------
     83 UniRef50_Q1K1Y8        Putative uncharacterized pr...    66     3e-10  1  11.6%   2:139 11:143     -VKGWFAALNKREQRLIVGTLFGAPLFVFIQLIFLPGLTEQTALERQVHQLEQDNTILQSQVLEMSLLAEKDPDADNRKKLEQLQQEIARFDQRLQENLSGL---VAPAQMPGLLR--SMLKQRAGLTLISMENAQPQA--------------
     84 UniRef50_Q2BKX2        MSHA biogenesis protein Msh...    66     3e-10  1  11.5%   3:132  9:133     --SAKWQGFSPRERILLLFTAVVAPVVLIFIFLLEPALITLQKTPAKIETLQTEINSQQRVLDLLRGQQVKDPNVAARAELK------KLRTQLSDVNNEIRRAATNLVTPDQMLSMLHslADDQGIKLVSA---------------------
     85 UniRef50_A1WTW3        MSHA biogenesis protein Msh...    66     4e-10  1  10.5%   2:144 10:147     -LNDALNARTPRERVLMVIAGLGVIGAGWYYLLFEPMQQRSADAQQRIESAEQQIRDLRTQRESLEAELGDDPEADVRAELDALRDEL---LALERDVGERVPEFIEPERMRQVLR--AVLAEHQGARLVRLERLPAQEVAGVE---------
     86 UniRef50_A1TKM9        Putative uncharacterized pr...    64     1e-09  1  14.2%   1:141 19:161     VLRARWKTLAPREQSLVLAAGTVVAVALLWWVALAPALRTLREAPAQHAALDAQLQRMQALQSeqLQAAPAAPAGDASQVLRTSLAQRLGSQAQISILGDRATVTLKAAPADGVAEWLSQARSNARAVPVEARLARSTAAA------------
     87 UniRef50_Q1YQU6        Putative uncharacterized pr...    64     2e-09  1  12.9%   2:140 10:152     -ISAWLSQRQPRERIIVVVGAGIVFVVAVYLALL-PSLERSTELQERHRILQADLHWLSEQSDSVSRLSNSCVDKTikDVINRLVRRNQIKLVKIAEQAQgyALSLESINANRLLQFAHQLA-CQGLKTNLLDVSRSDAT-------------
     88 UniRef50_A5F8T2        MSHA biogenesis protein Msh...    64     2e-09  1  12.4%   2:138  8:139     -FESRFSALSQREKVLITLCGSVLIVMMLLLGLIEPALKQGQARQLQMQTLTSSNLQLQGEIMALQAQLAKNPDQELDVELSQLTLQSQEISELLAAKMTSM---VAPSEMPNLLE--SVLKQGQQLKLVSLESLPAE---------------
     89 UniRef50_Q47HN4        Putative uncharacterized pr...    63     3e-09  1   9.0%   2:145 11:150     -LNKRYSSLAKRERQLVAVALILGPLLIGNALFVDPLRARLNGTENTIATESASAAQLQAEAANLQQQLAIDPDAGRKAELAALSGERDKLDEQLRQLGSAL---VRPEEMNALLERL--LARHPGLRLLSltLAPQSALGRVDV--------
     90 UniRef50_C6CIM7        Putative uncharacterized pr...    63     3e-09  1  15.0%   6:145  8:141     -----WRAFTRAQRRWLAAMGAIVIL----------LSALLVHVGEKSAQLHQASVWVAQQQDFTVWLAARPdaLPLQEALRRSAPPAALAAVFQYHPREAVLASPAAVGFNALFLWLSDLQQQYGISVVQLDVVPANEPGDIRL--------
     91 UniRef50_A3W189        Putative uncharacterized pr...    63     3e-09  1  17.8%   2:153  8:171     -LTGFLLGLSRRERWLVALLGLIALPLAAVYGIALPLADSRETARAAVAEARATELWVADQAVQFATLARDAGNGPKVAriEASLRDAGLrsQLANAADGGITLRFDAVRFTQLAEWLTSQNDIWGYDLAGFTFERGARTDVVAADLRLVAVQ
     92 UniRef50_D0Z1S9        MSHA biogenesis protein Msh...    62     5e-09  1   9.1%   2:133  7:133     -LDQKFAALSLREKWLITGCGFVAIFFVGIFTFIQPLMADADSAHLSTLDVKNQVITANNQVIVLNNKLKEDPD-----------AKINVNIAKLQHQETQLKLELdpQQMPALLE--HVLQQSASLHLVSME--------------------
     93 UniRef50_C8PZS1        Putative uncharacterized pr...    62     5e-09  1  13.1%   6:142 22:154     -----FQNLSRRDQIALLILAMFLLFFVVGVGGWT-LHSKANLAQKKYDDTMVDVFWLRSQAGNIN--PNQTQQVNQADAIKQILSQSGIVNAQVVENGNTIQVAFSHAQASVITNIFNQFEQ-QGIRIQQLQINQPALDKL-----------
     94 UniRef50_A6GLQ0        Probable type II secretion ...    62     6e-09  1   9.4%   3:140 11:155     --QAQLDQLNSRERKLVTYGGALAAVLIAWFVLIEPALLTIQQGPANQAALVDKAGQVMRAAQDLEALRGArpESDLQARLQQLLEEQGVSEqlVRTEEGDIRVEFNNVSASGFLAWMARAEAISSISLNLAEVEKVEAG-------------
     95 UniRef50_Q2S973        Putative uncharacterized pr...    62     7e-09  1   9.8%   1:132  1:130     MMKKWISRVNrrERGILLATVVVALILLYAQFAWEPLWRSNRSAEQAIAAANLELVDLSAQTDVLRKQLAQDPDAALRKENERLRNQLNARQERLKQNLSRL---VAPEEMPELL--MALLHKHPGLQVVAV---------------------
     96 UniRef50_B9TJM6        Putative uncharacterized pr...    61     9e-09  1  14.9%  38:151  1:117     -------------------------------------MDGAAQLHKELPQLHQQAAEMQVMAREAQALQGqaPSPMTREMLNAGLSARGLTPQSLNVTGEYAKLQFNGAQYAGIVAWLDAIRTESRINVVDASFTAQDAPGVVNGTLTLRQ--
     97 UniRef50_B1Y327        General secretion pathway M...    61     1e-08  1  13.5%   2:149 18:166     -LAQRWQALAPRERTGASLAIAALTLLLVWSVAIQPALRTLRTVPAQRAELDAQLARMQALAQEARELRALPPVAPEQSENarGATTRLGAGARLNLSGDRATVTLNAVDPAALTAWLAEVRSAARARVVELQLNRSGAGYSGTVVLTL----
     98 UniRef50_P25061        General secretion pathway p...    61     1e-08  1  12.6%   2:152 20:174     -LAIRWRGLPARDRLALLWLGAFLLLVVLYLALWRPAERHLQSARQYFTEQRALHAYIQQQAPNVRQADAAadPAALQGMVTASAAQAGLSVERLDNEGEgvQVALQPAPFAKLLPWLEQL-NGQGVQVAEAGLDR-QVDGRVSARLSLRVE-
     99 UniRef50_D0LLX2        Putative uncharacterized pr...    60     2e-08  1  13.3%   2:136  8:158     -LRDRWEQISPREQRMILVLGITFVVVVLALlgISGGLGAIEERNEQVRTALRSLGDYREHLAKGGGTPgpDEPVKLQSYLEGVATEVGITIPGFKPQTGSarIEVNGLSLSQLTAFLERVESKSpvMVEQLDIKR-----------------
    100 UniRef50_C5BR21        MSHA biogenesis protein, Ms...    60     2e-08  1   9.5%   3:139 14:145     --QAQFSKLSFRERILAGAGVFGLLLMAWHFAFLAPAISEQERLQQRFEQAQKELKSLGMEEQALVSAMSSDPSLVLRKRVDNLQAELNALDQHVQQMSAGL---ISAQRLPELLQ--AILKETSGLELVAMRIAAPQK--------------
    101 UniRef50_C6N6C3        Putative MSHA biogenesis pr...    60     3e-08  1  18.2%   2:138 14:145     -LKQKITHLSERDKVLLLFITVIILFTFWFLVIWEPQTNSINELNQKTEKVQGQIDALTQKKMIISILISNPNTAGifNELTTKLAKLNKEITRYNER------YISSRNLAKLLH--DMLKQTLGVTIDDFSTVPPP---------------
    102 UniRef50_A3ERG7        Putative uncharacterized pr...    59     4e-08  1  13.2%   2:153 19:194     -IKLRWEQLSRREKRLLSVLGTILALYLLQvfLMTPYQQYRDelRSDIFQALALSREIRQSQEKIRERSRtrGGFSLISYLEQEADRTHIRSSVTqpDGnlVSIRIEKVDLPHILVFLARLErrHLIRITRITLERrdQHRLLDVRIDVQSIQ
    103 UniRef50_C6WW12        Putative mannose-sensitive ...    59     7e-08  1  10.8%   1:139 11:144     LLSNKVESLNQRERLMVLGAAALLTYTVMQMLLLDSLETHKKRLLTEISTDQALVQELQQQTALYINKPPIDPDAQNKERIAE------LNTQLQALKSAQSQLDVSLISPEKMPELLRDLLSKNglKLIALNTLPTQN--------------
    104 UniRef50_B5FGN4        Msha biogenesis protein msh...    59     7e-08  1  10.4%   2:116  7:118     -VKEKFGALSQREKVLITLVGWVAVIFISLSLFIEPKIEQYHQSQQKVARITNSISSLKQQIELAEFRLKKDPNVEiqQLMIESQDLADLLFSRVASL-------VSPSQMASLLE-------------------------------------
    105 UniRef50_A6V156        General secretion pathway p...    56     3e-07  1  12.0%   2:151  8:154     -LHARWLRLPTRERRALLGLAAFLGLSLAWVLLWQPQRQALLDAERHYQDELRLHADLQRLPGDTGGGPRID-ATALPGLLARSSAQARLNVERMDSEGSGRMNLALEGQLADLLGWFESLGRS-GVEVTSLDLEVSPDA-LARARLAVEL--
    106 UniRef50_A8GJP6        Putative uncharacterized pr...    56     4e-07  1  20.3%  24:151 15:146     -----------------------AALIFCGMLVAVSLLAFYLQQKGQAQQANAELAQMQRNAQRIVMLRHPleGTSLQTLLKTSAEKLGLRLGTVRSDKNNLDVALPPQPVKPLLLWLENLQQAYGMGVNSIDLSLHGDEVRVQA-LTLQV--
    107 UniRef50_Q1D9F1        Putative uncharacterized pr...    56     4e-07  1   8.1%   2:149 11:178     -VQTWFERLSDRERRMVSIAglVFVLFAVVMTFTNSASGYRKRTEEKLTKLQelAASFREAQANRQSVEqrSSNVQLISYIEDKATLAGLQVPNMTPKGeaVELTFTDVDLRKLTDFLQTVESGPgvKVKLLRIEPRPASDTLTAWTTV----
    108 UniRef50_B4WDR0        Putative uncharacterized pr...    55     6e-07  1  12.9%   4:142 10:147     ---AWWDGRTLREQRMLTVMGLAIAAVLVWLLIVRPAWAWRADAAEARAVAEADLALVQTATGRMARTDAASSDVDVAAVVAEVGSITGVTPVMGMSPDGGLGFNLTNVSSTAAFGWLAALHDRK-VEATTLNVVENADATI-----------
    109 UniRef50_C6BWY4        ABC-type nitrate/sulfonate/...    55     9e-07  1  12.4%    6:94   8:94     -----WNKLDPRDRRALGICLIFLFSVVLYMGVLAPLGNMY---EATVQEQVELKQEIQLNTPKAMVLPDREAkrQVKNEYESLKRQLDLVDRR-----------------------------------------------------------
    110 UniRef50_B2A7F6        Putative uncharacterized pr...    55     1e-06  1  15.6%    2:65   8:71     -LINKLSSLSKRERLLLMIAGILVVFVSFWQFIFIPFENRRSELEKNIDHTQQNINHLQGKLSEW----------------------------------------------------------------------------------------
    111 UniRef50_Q2KZN1        General secretion pathway p...    54     1e-06  1  15.6%  19:153 39:184     ------------------AVSAILAAAVIFLGFIEPPLAKLARLRTDLPSLRIQAAAVDDLAARASALSRRAqeLPTPSDLRGSLIHAGLPADhlTREDAVYVLTLNDVPAQRLLDWLETSARDWGLLARQAELARapLPGLVNASLRLALTQ
    112 UniRef50_B0TEF5        Putative uncharacterized pr...    54     2e-06  1  11.6%    4:98 35:147     ---NWWMARTKRERVLLSLFGAAVAGAGLYLLVLEGQLDQFSTLSTELPVSKQQLESAKRRIQniSAYPAALSSGSMAVLIGEAAKASKVTIKYFVPQ-------------------------------------------------------
    113 UniRef50_Q4KD21        Probable type II secretion ...    53     3e-06  1  18.3%   6:131 24:154     -----WNGLALREKRLLGATALGLLGLLLWLLLIQPPLKKIDYWQAETPKLRSQAEALEVLLHEVAAGSRNAPGESLEQALRQALDAAGLQGRYqqAGPESWRLTFEQAPADAVVGWLLGAPRQFSLQVVE----------------------
    114 UniRef50_C4ZCH2        Putative uncharacterized pr...    52     4e-06  1  13.2%    9:76   1:68     --------MSTRDKKLLIILAGVAILALTYFLIFMPQSNKRDSLKSENMNLKSQYNQLSALAAKADDYTKKTKDMS-----------------------------------------------------------------------------
    115 UniRef50_A7C5U9        Putative uncharacterized pr...    52     5e-06  1  10.5%  75:150   2:80     --------------------------------------------------------------------------QSLLNLIDKSTRIGALRNANKQIEaqEVRVNFEEVSFTDLMRWLGQLYNQHQIQVSTMSIEQKHKPNKVKVRLTLK---
    116 UniRef50_B1I3E4        Putative uncharacterized pr...    52     7e-06  1  11.4%    6:93   2:87     -----WQNLSERQRLLVMVAATVLVFALLYLLVLSRQISAFQRAGAALEATSAELQQYRAKAARFEVEKEREAASQIR--LEELSRHFDTNYQ------------------------------------------------------------
    117 UniRef50_Q1QBS3        Putative uncharacterized pr...    52     8e-06  1  13.2%   1:152 30:186     LLFVRWQALSSRDQLALLLLSAFLLLFIGGYGGYS-IHQAANHSKSEYQEQVADYFWLRAQAGNIDSNALAAANtpATSSVNALLTNSGIVDAQVIANGNTVQLSFNNPSQAVVSAALGKLEQ-QGWQFTQLSMQQDLLTKAIQVQATVTLS-
    118 UniRef50_C6HW27        Putative uncharacterized pr...    51     9e-06  1  15.6%   7:153 30:200     ------ERLTPREKRLVRILLSLVGGIVLWQGVTLVFWDPYQAREAELADLRSETLKVATLAREiqRLAREERGFSLISTLEEEADKAHirITRMTPRtaMVSLEIDSVDLPHALVFLARIQRSPhiRVTRLSMKRrnDHSKIDLSLDVEAVQ
    119 UniRef50_B8D2D7        Putative uncharacterized pr...    50     2e-05  1  20.0%    6:55   2:51     -----WHNLSDREKKLIIFGLIAVICMVYWFYGEQPTTRTIDELESDLQQLRREL--------------------------------------------------------------------------------------------------
    120 UniRef50_A9GDP3        Putative uncharacterized pr...    50     2e-05  1   9.1%   2:100  3:109     -LRERLDKLEPRERRLLTILLGFLAVIVL-LLVPIGLASVASSKRAENQEIRDLLQSIYEASGKVSERKaaRPAPALAGFIEDAAKQQQLTAAESQDRPD-----------------------------------------------------
    121 UniRef50_A9IRQ5        General secretion pathway p...    49     4e-05  1  16.7%   4:141 35:192     ---SWYALRPRREQRLLACAGALLAAALVFLLLVEPAWSTMTRTRQELPDLRAQTATVAELTAQVRALRRRDAGAATAseLTASLRREGLPDseAAAPASAIRLNLREASAAALFRWLDTAARDWRLSVADAELARATNPA------------
    122 UniRef50_UPI00016990A6 hypothetical protein Epers_...    47     2e-04  1  14.7%    2:96  1:102     -MIRWFYAKPPRERLALLTGGASLLILLIYLLVWTPFISKLERKQAQLESQRATLAWLQSAVSEVAQLRAAQpnESLFTLVDRTATQNRLRKQIDQ---------------------------------------------------------
    123 UniRef50_Q12DW5        Putative uncharacterized pr...    46     3e-04  1  12.4%   2:138 10:147     -LQARWHALGQREQTLLRSVALLVGLALLWWGLMAPPLRTLRQAEAQQRSLDAQWQKMQGLRAQAQAL-QSQPRISRDDALRALQASVKlaSAQLSVVGDRATVTLRNTPADALAQWLAQARANAGAIPDEARLVRNA---------------
    124 UniRef50_A7C5V0        Putative uncharacterized pr...    46     3e-04  1   9.5%    4:45   2:43     ---NWFKQLAPHERRTLMIGTIALSSLLFYFLIWEPFVTARTQLE------------------------------------------------------------------------------------------------------------
    125 UniRef50_Q21LN4        Putative uncharacterized pr...    55     6e-07  1   8.0%   1:138  4:143     LLQQKwnARNTRERALIAVSCWAMIYLVWDFAFFQPLNKQKEALQQRFDATNQTLVQLDAQQQVFVRALSSDPNAGRRREIVALKESITVLDNEINRLSDGL------IPAPKLPQLLHdlRANNNLKLVSMRTQPAE---------------
    126 UniRef50_A0YA33        Hypothetical MSHA biogenesi...    52     5e-06  1  11.1%   3:137  9:138     --KSKFDVLAQRERILLLVCAAVVTIMLMQVVLLDPLLGTSKKISSRAAEASGKISRYQAEKQVVEAQLGVGVEGAKKEQLERLESEL---DDLNEEIEDSVQGMIPPRLMPEVLE--KVLLESQGLKLLSLENQPV----------------
    127 UniRef50_B4S2I3        Putative Mannose-sensitive ...    49     5e-05  1   8.0%   2:138  7:138     -LSEKFSALEGREKQLILWVSFGLIVYLFFWFGILPALDDLSTADKAVKRKSSEYNALVIQRDAVQQALSIDYTQRTQQELDSARKALLAIDEELLSLNEGF---VAADRMPELL--MTLLNEENNVRLVNFNVEPTQ---------------
    128 UniRef50_Q12IV1        MSHA biogenesis protein Msh...    45     0.001  1   9.4%   2:139  8:139     -LASKFNELSQRERVLVGFASLVLVVFSCFMLL-EPMLLDNQQRAQHLKELHHSNQMASQSIAVYQQGLSLDPDADYKQRLAMLEQQLIFVDAELSEQM------VDMIPADYMPAVLAqlSQVKGLTLLGFSSLPPQA--------------
    129 UniRef50_A1TYM9        Putative uncharacterized pr...    44     0.002  1  10.3%   3:138 12:142     --SQWYNDRPIRERVLVLLTVCVLVFVVGWELLVAPAEARKSQLASQLQVASNTRDALLSQQESLDGQLASDPSTELRERLAARENRLSRLNEQIAETTGQL---IAPRDMVVLLR--EMLAAQQGLELDSMELLAPE---------------
    130 UniRef50_A6FG32        Glucose-6-phosphate isomera...    43     0.002  1  10.9%   1:137  1:139     MMKQHwrQLSMRERILIVVSLVASVIYVIDSFVLAPNYARHKQLTSQLSSLGQQQRQHGFTLAELQRVLATDPNKVIKLRILRAENTLKKANGKLTDLTADL---INSNQMALVLG--DVLSRAKKVKLIAIESLPV----------------
    131 UniRef50_C0QUI9        Putative uncharacterized pr...    43     0.002  1  14.1%   2:100  6:104     -LKAQWAELPEWQKILVIVLFSVLLLYGIYMVMIESKLTEKKNLQDEVQSLQLQVERLKRAARPEIRKKLEEKYVMVQKEIEQLNKQLERLKDIVPPQED-----------------------------------------------------
    132 UniRef50_Q1JVU6        Putative uncharacterized pr...    42     0.004  1  16.5%   8:134  4:152     -------QLSPRELAMVLVAAIFVIATVIYLAMIAPYVATMERLDSKIASRQQQLQqiQGQIKSLQRRQASAGDFALFAYVerIAGRENLTSMRPMptEEAVEIKLENVSLGQMLQLLQSFNSAppLQVKALQL-------------------
    133 UniRef50_C8R0C1        General secretion pathway M...    42     0.005  1  10.8%   2:149 11:172     -LEARLEGlpPRQRPLLFIGLGLLVPLLVWLLLLAPLGSSRDSLQRDIGAREQELAWMREAAQEVQRYagARPGGSPLAAIDSSAREFGlaMQRVEPGDGG-----------EVrrWLDRLGRGHGIEAVEVVVEPagRAARVNARLTL----
    134 UniRef50_C5CPK5        Putative uncharacterized pr...    42     0.007  1  15.8%   2:140  7:149     -LRARWAALELRERRMVAIAAALVVLALLWWVALAPALRTLAAAPADHAQLDAQLQQmqNRAKALQAQPRLNRDDALRALETSVRESLGTNAQLMTASGDgaTITMRATPADAVAQWLAQARGNAHAVPREAHLTRAAAG-------------
    135 UniRef50_A4BG91        Putative uncharacterized pr...    42     0.007  1   4.5%   7:138 14:140     ------ERLSRRERILLLVVLFAVILAAAQSTLMLSGLDRHDRVREQITNVRQQTQATRQALLDYQAAINNPQIQALRDNNDDLRTRIEDLEARIANINSQL---MSPERMISLLKEL--LNDYSNLTVTRFEVQPVE---------------
    136 UniRef50_Q2LVK9        Hypothetical membrane prote...    42     0.008  1  11.0%   5:150  9:178     ----YWSGLRQRERIVLGGGLICLFLLLLTHFILLPFFEARDKMTRSIARQEKVLQELTELKAQYQSLkrRSPDFTMASHLDRIINeqDFQSTKSQAGEgrTEIKIARVTMDQLIQFLYLAEseYGIWIEQISIAGGpeTGFLSATLALK---
    137 UniRef50_A8VRE6        Periplasmic binding protein...    42     0.008  1   9.2%  10:140 84:215     ---------SFRKQSALIGAGIGAVLLILFVVFwqPldQKYNMADGEEVTVDELNPVNEENIPVVPRSYAEYRSDILMGQLPNQAF-YNLGTTRIQQHDGSL-YWVTPIEYDGLFRWIRS-DAAPGFIVVSAE-NPREEP-------------
    138 UniRef50_UPI0001979A79 hypothetical protein HcinC1...    42     0.009  1  13.9%   2:138  9:174     -ITQFLSTKTKREKILLFIAIMALCVFIMMEFIYLPLLqqHQQQTNEVQNLQEEIFSLQQSLSHTTTLEPLLNPFTLIPSLINFAKNENLTLNAFHPHPTLNALVIEGseFWQILNLLSFLENLHFVSLESLELSSQE---------------
    139 UniRef50_UPI00016990A5 hypothetical protein Epers_...    41     0.012  1  17.1% 106:146   1:41     ---------------------------------------------------------------------------------------------------------MENAAFDAMLRWLGLLQQQYRIQVVSMNIDSKDKPGRINAR-------
    140 UniRef50_B8FH98        Pilus assembly protein PilO...    41     0.013  1  16.1%   8:100 20:130     -------QLSRPQRILIFVAAFLVIGALFTFLLFKPYWTQKSELTTKLENKLNEVRVSQAKAAKleSLPKKKEVPELLDRMSLSGKEAGLEWTLFQPRSE-----------------------------------------------------
    141 UniRef50_C1I9R4        Type IV pilus assembly prot...    41     0.014  1  11.3%    8:69   2:63     -------NISKREKYLIGILLTVLICFVYYQFIYTKQVGKLATKRAEKNQVEQRYNDVMDNISKLDSKE------------------------------------------------------------------------------------
    142 UniRef50_C9YDY7        Putative uncharacterized pr...    40     0.020  1  14.2%  16:149  1:135     ---------------MLTLAAVLVLGTLLWTVGIAPALRTVKAYPAQRGTLDAQLQSMQALQMRAQNlgQPAVDGRAAQAALQSTVASLGTKANLLVIGQQATVTFRGLDAAVLAQWLARARSEARLVPAQAKLSREGSSWSGTVQFNL----
    143 UniRef50_B8GLD3        Putative uncharacterized pr...    40     0.021  1  11.4%  14:153 19:155     -------------RRALIWGGLAVALILAGWGLFEAGQnrHSDARGEIRELQRRVASLERTNRELVQRNARLERGQIIEKAAAERLRENLAdtRLQSMDEELTFYRNIVSPENL---------ESGLHIHSFVLEPVGASGEYVFRAVLTQIR
    144 UniRef50_D0FPJ4        Conserved uncharacterized p...    40     0.021  1  10.3%   4:139  7:139     ---NFWQRRQPRERWLLVICLISAIAAGLYIAREQ-AMVWQQRAVNHLQQRQLEAQQIQQLESRMQAVLARQPEKNP--GLEQLNRLLPPGLVLSQPSPDLWVAARGTVALGSLLNALVKLEQRYALQPSHLLLEQQGT--------------
    145 UniRef50_A3WP68        Type II secretory pathway c...    40     0.026  1   9.5%   11:94 16:100     ----------PRDRrlIAILVWVLIAVYMGSTLLLPNIKAMNSSKLRTEQLAQQLSQVRALNEQLKSQLQQDVNQPIRDDIERKQARLTQLVER-----------------------------------------------------------
    146 UniRef50_Q8RAE9        Fimbrial assembly protein n...    39     0.052  1  12.3%   8:153  2:150     -------KLTKREKFLIYFALVFAFFAIYYQFYLIPKLSEIDNLSQEIKLKRQILSQVSSLKGeqKSLAKWEKEVEELNAILPDEKDAEFAILDLQRMASDSGVKIRSINFENASQEEKNKEQKEEFAVTPISVTAFGsdGLISFMKSLQESR
    147 UniRef50_Q3A7K1        MshA biogenesis protein, Ms...    39     0.059  1  13.1%   4:133 13:137     ---DWLDQRSLRERVLLAAVVLVVGFLVFDALVFHPQAQNRRHLKTQMATLETTLAELDRQAETVLLRAKEDPDREHRAQQRQLQAELASLDERLKDLTVDL---ISPSDMAEVLREL--LARQQGLRLVHLE--------------------
    148 UniRef50_Q670M6        MshJ n=2 Tax=Pseudoalteromo...    38     0.065  1  10.0%   3:102  9:108     --REKFAALQMREKYLIFGVGLFLICYLFGFYLLNPLYLKWQKNAQSLIAIEKKLVANTAQITLFSDALTRDYTQELRSEIATAELALKQVDEKLNQFSQGF---------------------------------------------------
    149 UniRef50_C1XGT3        Putative uncharacterized pr...    38     0.076  1  15.2%  11:148  3:121     ----------QREWAIVAIVAALLLGMMWYFFVTQPLQGRIPELQAEVDRLT---------VERDRGRAAQRALPQLRETIARLDAERQQFLRELPP----------TEQLGRVLSSLAQTARESGVVLRALSRSPGDNQGVANVRAT-----
    150 UniRef50_Q3SKR0        Putative uncharacterized pr...    38     0.093  1  15.4%    2:79   9:86     -LGERIEGMSPRERAFVFAAAVMLALALVQTLVIDPARERQQRAQERVQSARAALQQIAQQTAAVRDTLRVDPDRTARD--------------------------------------------------------------------------
    151 UniRef50_C6P4S8        Putative mannose-sensitive ...    38     0.096  1   8.3%   7:138 15:141     ------DGMSLRERALIFAAAAFLAVSLIDSLFLEPLLDKQKKLSAQVIQQQEKMKETEAQIAALLQAKQADANSPQRERIRVLRQQIADGDAYLKGRRDKL---VPPEKMAQLLE--QVLNRNDRLKLVALNTLPVS---------------
        consensus/100%                                                                                     .........................................................................................................................................................
        consensus/90%                                                                                       .......h..p-p.hl.hhhhhhhhhhh..hhh.s..t..tt..tt..t..t....h......................h................................h.......................................
        consensus/80%                                                                                       ....htths.R-phhlhhhhhhhhhhhhh.hhh.Ph.tthtphptph.t.tt.ht.hpt.h..h.t..t...s..h.t.ltt..tt.th..t..t..tt.h...ht...h.thh.....h....th.h.thp...................
        consensus/70%                                                                                       ...hapths.REphhlhhhshhlhhhlhahhlhtPh.pthpphptphtphpppht.hptthtthtth.tttsstsltthlpp.ttphth..tthpststth.h.ht.h.hstlhthlt.lttt.tlpl.thpht..t............

MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown